Clinicopathologic Factors Associated With Response to Neoadjuvant Anti-HER2-Directed Chemotherapy in HER2-Positive Breast Cancer. [electronic resource]
Producer: 20210329Description: 19-24 p. digitalISSN:- 1938-0666
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Biomarkers, Tumor -- analysis
- Breast -- immunology
- Breast Neoplasms -- genetics
- Carcinoma, Ductal, Breast -- genetics
- Chemotherapy, Adjuvant -- methods
- DNA Copy Number Variations
- Drug Resistance, Neoplasm -- genetics
- Feasibility Studies
- Female
- Humans
- Lymphocytes, Tumor-Infiltrating -- immunology
- Mastectomy
- Middle Aged
- Neoadjuvant Therapy -- methods
- Predictive Value of Tests
- Progression-Free Survival
- Receptor, ErbB-2 -- antagonists & inhibitors
- Receptors, Estrogen -- analysis
- Receptors, Progesterone -- analysis
- Tumor Burden
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.